# Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer

> **NCT01370876** · PHASE2 · TERMINATED · sponsor: **Nang Kuang Pharmaceutical Co., Ltd.** · enrollment: 46 (estimated)

## Conditions studied

- Cancer of the Head and Neck
- Neoplasms, Head and Neck

## Interventions

- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT01370876
- **Lead sponsor:** Nang Kuang Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-09
- **Primary completion:** 2011-08
- **Final completion:** 2012-05
- **Target enrollment:** 46 (ESTIMATED)
- **Why stopped:** company policy
- **Last updated:** 2013-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01370876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01370876, "Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01370876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*